Overall, the CD59 loss of function mutations in case series of patients with CIDP-like phenotype, along with the response to complement inhibition, suggests a direct link between compliment activation and acquired chronic peripheral nerve demyelination. Here, CD59 is linked to chronic inflammatory demyelinating polyradiculoneuropathy.